Featured Post from University of Delaware

America's literacy emergency continues; experts available with solutions

University of Delaware education scholars offer research-backed solutions for the nation's continued literacy problem.

Sep 18, 2025

2 min

September is more than back-to-school season. It is also National Literacy Month. This return to the classroom and yearly recognition remind us of the urgent need to ensure every child has the literacy skills to thrive in school and beyond.


One such example of this is Delaware. 


Despite recent gains in statewide test scores, Delaware leaders have warned: a literacy emergency persists. Too many children – especially those from marginalized communities – are still being left behind in reading proficiency. The University of Delaware’s College of Education and Human Development is helping to change that.


CEHD’s literacy experts are advancing research, building partnerships, and equipping educators with evidence-based strategies that make an impact.


Annastasia Purinton and Steve Amendum work with the WTG Foundation to strengthen school-community partnerships that bring literacy support directly to students who need it most.


Stephanie Del Tufo, whose recent essay in The Conversation spotlighted the science of reading, studies how early learning and memory processes shape literacy development.


Adrian Pasquarella focuses on multilingual learners, helping educators bridge language learning and literacy growth – an area of growing importance in Delaware’s diverse classrooms.


Rebecca Joella and colleagues at the Delaware Institute for Excellence in Early Childhood are leading professional development efforts that equip early educators to foster strong literacy skills from the start.


These experts bring research to life – translating what works in the classroom into scalable practices and policies. Their work underscores a powerful truth: literacy is not just an academic milestone, it is the foundation for opportunity, equity and lifelong success.


As Delaware and the nation confront the literacy crisis, CEHD stands at the forefront with the evidence, expertise and partnerships to make a lasting difference.


To speak to any of these experts, please email mediarelations@udel.edu. 

You might also like...

Check out some other posts from University of Delaware

1 min

Soaring gold prices could bring big rewards – and even bigger risks

This week, gold prices surged to record highs, reshaping both the financial and geopolitical landscape. The University of Delaware’s Saleem Ali can explain the potential environmental, social and economic ripple effects of this gold rush and the opportunities and risks it creates. He says a controlled release of global gold reserves could help ease market pressure and mitigate the negative impacts. Ali, a professor of energy and the environment, can discuss the following main points: • The record gold price (which dipped slightly today) has implications for new gold mining projects becoming more financially attractive which could have environmental and social implications in those areas. • Major gold trading hubs like Switzerland and Dubai will need to be more vigilant as gold will become more attractive for the illicit economy for commodities. • We have major global bank reserves of gold even though the gold standard is no longer used to back currency. Some of these reserves could be liquidated to reduce pressure and negative externalities. Such a controlled release of gold reserves could help to manage the price rise. Ali also serves on the Independent Governance Committee for the Dubai Multicommodity Center, which manages all of the gold coming into the United Arab Emirates. To reach Ali directly and arrange an interview, visit his profile and click on the “connect” button. Interested reporters can also send an email to MediaRelations@udel.edu.

6 min

Taking discoveries to the real world for the benefit of human health

It takes about a decade and a lot of money to bring a new drug to market—between $1 billion to $2 billion, in fact. University of Delaware inventor Jason Gleghorn wants to change that. At UD, Gleghorn is developing leading-edge microfluidic tissue models. The devices are about the size of two postage stamps, and they offer a faster, less-expensive way to study disease and to develop pharmaceutical targets. These aren’t tools he wants to keep just for himself. No, Gleghorn wants to put the patented technology he’s developing in the hands of other experts, to advance clinical solutions in women’s health, maternal-fetal health and pre-term birth. His work also has the potential to improve understanding of drug transport in the female reproductive tract, placenta, lung and lymph nodes. Gleghorn, an associate professor of biomedical engineering, was named to the first cohort of Innovation Ambassadors at UD, as part of the University’s effort to foster and support an innovation culture on campus. Below, he shares some of what he’s learned about translating research to society. Q: What is the problem that you are trying to address? Gleghorn: A lot of disease has to do with disorganization in the body’s normal tissue structure. My lab makes microfluidic tissue models, called organ-on-a-chip models, that have super-tiny channels about the thickness of a human hair, where we can introduce very small amounts of liquid, including cells, to represent an organ in the human body. This can help us study and understand the mechanism of how things work in the body (the biology) or help us do things like drug screening to test therapeutic compounds for treating disease. And while these little microfluidic devices can do promising things, the infrastructure required to make the system work often restricts their use to high-end labs. We want to democratize the techniques and technology so that nonexperts can use it. To achieve this, we changed the way we make these devices, so that they are compatible with standard manufacturing, which means we can scale them and create them much easier. Gleghorn: One of the problems with drug screening, in general, is that animal model studies don’t always represent human biology. So, when we’re using animal models to test new drugs — which have been the best tool we have available — the results are not always apples to apples. Fundamentally, our microfluidic devices can model what happens in humans … we can plug in the relevant human components to understand how the mechanism is working and then ask questions about what drives those processes and identify targets for therapies to prevent the dysfunction. Q: What is innovative about this device? Gleghorn: The innovation part is this modularity — no one makes these devices this way. The science happens on the tiny tissue model insert, which is sandwiched between two pieces of clear acrylic. This allows us to watch what’s happening on the tissue model insert in real time. Meanwhile, the outer shell’s clamshell design provides flexibility: if we’re studying lung tissue and we want to study the female reproductive tract, all we do is unscrew the outer shell and insert the proper tissue model that mimics the female reproductive tract and we’re off. We’ve done a lot of the engineering to make it very simple to operate and use, and adaptable to common lab tools that everyone has, to eliminate the need for financial investment in things like specialized clean rooms, incubators and pumps, etc., so the technology can be useful in regular labs or easily deployable to far-flung locations or countries. With a laser cutter and $500 worth of equipment, you could conceivably mass manufacture these things for maternal medicine in Africa, for example. Democratizing the technology so it is compatible and useful for even an inexperienced user aligns with the mission of my lab, which focuses on scaling the science and the innovation faster, instead of only a few specialized labs being a bottleneck to uncovering new mechanisms of disease and the development of therapies. We patented this modularity, the way to build these tiny microfluidic devices and the simplicity of how it's used as a tool set, through UD’s Office of Economic Innovation and Partnerships (OEIP). Q: How have you translated this work so far? Gleghorn: To date, we've taken this microfluidic system to nine different research labs across seven countries and four continents — including the United States, the United Kingdom, Australia, France, Belgium and South Africa. These labs are using our technology to study problems in women’s health and collecting data with it. We’re developing boot camps where researchers can come for two or three days to the University of Delaware, where we teach them how to use this device and they take some back with them. From a basic science perspective, there is high enthusiasm for the power of what it can tell you and its ease of use. As engineers, we think it's pretty cool that many other people are using our innovations for new discoveries. Q: What support and guidance have you received from the UD innovation ecosystem? Gleghorn: To do any of this work, you need partners that have various expertise and backgrounds. UD’s Office of Economic Innovation and Partnerships has built a strong team of professionals with expertise in different areas, such as how do you license or take something to patent, how do you make connections with the business community? OEIP is home to Delaware’s Small Business Development Center, which can help you think about business visibility in terms of startups. Horn Entrepreneurship has built out impressive programs for teaching students and faculty to think entrepreneurially and build mentor networks, while programs like the Institute for Engineering Driven Health and the NSF Accelerating Research Translation at UD provide gap funding to be able to do product development and to take the work from basic prototype to something that is more marketable. More broadly in Delaware is the Small Business Administration, the Delaware Innovation Space and regional grant programs and small accelerators to help Delaware innovators. Q: How have students in your lab benefited from engaging in innovation? Gleghorn: Undergraduate students in my lab have made hundreds of these devices at scale. We basically built a little manufacturing facility, so we have ways to sterilize them, track batches, etc. We call it “the foundry.” In other work, graduate students are engineering different components or working on specific system designs for various studies. The students see collaborators use these devices to discover new science and new discoveries. That's very rewarding as an engineer. Additionally, my lab focuses on building solutions that are useful in the clinic and commercially viable. As a result, we've had two grad students spin out companies related to the work we've been doing in the lab. Q: How has research translation positively impacted your work? Gleghorn: I started down this road maybe five years ago, seriously trying to think about how to translate our research findings. Being an entrepreneur, translating technology — it's a very different way to think about your work. And so that framework has really permeated most of the research that I do now and changed the way I think about problems. It has opened new opportunities for collaboration and for alternate sources of funding with companies. This has value in terms of taking the research that you're doing fundamentally and creating a measurable impact in the community, but it also diversifies your funding streams to work on important problems. And different viewpoints help you look at the work you do in new ways, challenging you to define the value proposition, the impact of your work.

2 min

Delaware study reveals higher rates of anxiety, substance use among LGBT+ youth

A new study has found that LGBT+ youth in Delaware are experiencing disproportionately high rates of anxiety, depression and substance use compared to their cisgender heterosexual peers. University of Delaware’s Eric Layland, assistant professor in the College of Education and Human Development, and his coauthors reported that nearly one in four Delaware teens identifies as LGBT+, a dramatic increase from earlier state surveys that put the figure closer to 5%. More than one in 20 identified as transgender or nonbinary, reflecting national trends of increased visibility among Generation Z. The study revealed stark mental health differences. About half of cisgender heterosexual youth reported recent anxiety, compared to 75 to 80% of LGBT+ youth. These rates exceed both their heterosexual peers in Delaware and national averages for LGBT+ youth. Substance use patterns also raised concerns. By 8th grade, LGBT+ students reported higher rates of drinking, smoking, vaping and prescription drug misuse. Researchers noted that their substance use looked more like that of 11th grade heterosexual students than their peers in the same grade, pointing to early onset of risky behaviors. These disparities, established in middle school, largely persisted into high school. While substance use increased among all students over time, LGBT+ youth consistently reported higher rates. Based on state population data, the findings suggest there may be 18,000 to 20,000 LGBT+ youth in Delaware, including up to 5,000 transgender and nonbinary youth. The authors say this underscores the importance of ensuring that schools, healthcare providers and community programs have the resources to meet the needs of this population. This is one of the first Delaware-specific studies on youth health disparities by sexual orientation and gender identity using data collected after the height of the COVID-19 pandemic. The results, researchers say, highlight an urgent need for early intervention and affirming support systems for LGBT+ youth across the state. Layland, who specializes in LGBTQ+ development and affirmative interventions, can speak more about specific interventions. He is available by clicking his profile. 

View all posts
Powered by